Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

130877 Press Releases
DateTitleCompany
24 Nov 15 ACETO Subsidiary, Rising Pharmaceuticals, to Launch Dutasteride Softgel Capsules ACETO Corporation ,
Published by
PharmiWeb.com
24 Nov 15 ACETO Corporation Announces the Exercise in Full of the Over-Allotment Option in Its Convertible Notes Offering ACETO Corporation ,
Published by
PharmiWeb.com
24 Nov 15 FDA Approves Immunotherapy Drug Opdivo to Treat Renal Cell Carcinoma The Conference Forum,
Published by
PharmiWeb.com
24 Nov 15 Merge Healthcare and eviCore healthcare Partner to Streamline Medical Imaging Prior Authorization Process for Providers and Payers Merge Healthcare ,
Published by
PharmiWeb.com
24 Nov 15 Merge Healthcare and AIM Specialty Health Join Forces to Support a Technology-Driven Approach to Medical Imaging Prior Authorization Merge Healthcare ,
Published by
PharmiWeb.com
24 Nov 15 Brickell Biotech Secures Exclusive World-Wide Rights to a Novel Class of RORγ Inhibitors for Psoriasis and Other Autoimmune Diseases Brickell Biotech ,
Published by
PharmiWeb.com
24 Nov 15 ERS Genomics Licenses Genome-Editing Patents to Regeneron Pharmaceuticals ERS Genomics ,
Published by
PharmiWeb.com
24 Nov 15 EDELRIS Announce Exclusive License Agreement with ENYO Pharma EDELRIS ,
Published by
PharmiWeb.com
24 Nov 15 Uni-Bio Science Acquires Global Rights to Type 2 Diabetes Drug Mitiglinide from Jiangsu Hansoh Pharmaceutical Co. Ltd Uni-Bio Science ,
Published by
PharmiWeb.com
24 Nov 15 Uni-Bio Science Acquires Global Rights To Type 2 Diabetes Drug Mitiglinide From Jiangsu Hansoh Pharmaceutical Co. Ltd Uni-Bio Science ,
Published by
PharmiWeb.com
24 Nov 15 Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’) the global pharmaceutical and services company, announces that its global leading Clinical Trial Services business (Clinigen CTS) has renewed an exclusive European Union (EU) clinical trial distribution agreement with Accord Healthcare (‘Accord’), a wholly-owned marketing subsidiary of Intas Pharmaceuticals, for a further two years. Clinigen ,
Published by
PharmiWeb.com
24 Nov 15 BSN medical Announces Acquisition of Wright Therapy Products, Inc. BSN medical ,
Published by
PharmiWeb.com
24 Nov 15 Circassia Announces Positive Outcome of European Decentralised Procedure for Approval of Its Fluticasone Propionate Equivalent of GSK’s FLIXOTIDE® pMDI Circassia ,
Published by
PharmiWeb.com
24 Nov 15 Midwest Imaging Implements eRAD’s uniRAD Global Worklist With Integrated Speech Recognition Published by
GlobeNewswire
24 Nov 15 Tips for traveling with heavy luggage this season American Academy of Orthopaedic Surgeons,
Published by
PR Newswire
24 Nov 15 Versatile Role of Insulin Highlighted in Special Issue of Diabetes Care American Diabetes Association,
Published by
PR Newswire
24 Nov 15 Copeman Healthcare, Canada's Pioneer in Private Primary Care Celebrates 10 Year Anniversary Copeman Healthcare Centre Inc.,
Published by
PR Newswire
24 Nov 15 22nd Century Group to Open Laboratories to Lower Costs of Research and Speed Development of Important New Products 22nd Century Group, Inc.,
Published by
Business Wire
24 Nov 15 Spine Biologics Market Worth $2.4 Billion by 2020 MarketsandMarkets,
Published by
PR Newswire
24 Nov 15 AMD LASERS Announces Expansion Into the Hard Tissue Dental Laser Market AMD LASERS,
Published by
PR Newswire
24 Nov 15 Zero Gravity Solutions, Inc. Receives Notification of Patent Approval for its Commercial Product, BAM-FX from the United States Patent and Trademark Office Zero Gravity Solutions, Inc.,
Published by
Business Wire
24 Nov 15 New Devices Allow Patients to Deliver High Viscosity Injectables by Self Administration Greystone Research Associates
24 Nov 15 Adaptimmune Initiates Phase I / II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients With the Most Common Type of Lung Cancer Adaptimmune Therapeutics plc,
Published by
GlobeNewswire
24 Nov 15 UPDATE -- Merge Healthcare and AIM Specialty Health Join Forces to Support a Technology-Driven Approach to Medical Imaging Prior Authorization Published by
GlobeNewswire
24 Nov 15 GW Pharmaceuticals to Present at the Piper Jaffray 27th Annual Healthcare Conference Published by
GlobeNewswire
24 Nov 15 Sera Prognostics to Present at 27th Annual Piper Jaffray Healthcare Conference Published by
GlobeNewswire
24 Nov 15 Intellipharmaceutics to Present at the LD Micro Main Event Published by
GlobeNewswire
24 Nov 15 Adaptimmune Initiates Phase I / II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients With the Most Common Type of Lung Cancer Published by
GlobeNewswire
24 Nov 15 GW Pharmaceuticals to Report Q4 and Year-End 2015 Financial Results and Host Conference Call on 3 December, 2015 Published by
GlobeNewswire
24 Nov 15 Coming Soon to Big Pharma: Disruption Innovation Pharma Integrates ,
Published by
De Facto Communications
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.